MG TEST

A recent ARUP study was quoted during a Congressional committee hearing on the FDA’s proposal to regulate lab-developed tests as medical devices. https://ow.ly/mz7550QZfIM #FDA #laboratorymedicine

Scheduled Medicare cuts will undermine laboratory infrastructure, while also stifling investments in innovative new screening and diagnostic tests. Congress – it’s time to pass the Saving Access to Laboratory Services Act (#SALSA): https://bit.ly/49QU2ZE.

This morning, @ACLAPresident Susan Van Meter will testify before the @HouseCommerce’s Subcommittee on Health for a hearing on laboratory developed test regulation and the potential impact of @US_FDA’s proposed rule.